rs61742476

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002471.4(MYH6):​c.4838T>C​(p.Val1613Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0104 in 1,612,612 control chromosomes in the GnomAD database, including 600 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V1613I) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.037 ( 315 hom., cov: 32)
Exomes 𝑓: 0.0076 ( 285 hom. )

Consequence

MYH6
NM_002471.4 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 8.00

Publications

5 publications found
Variant links:
Genes affected
MYH6 (HGNC:7576): (myosin heavy chain 6) Cardiac muscle myosin is a hexamer consisting of two heavy chain subunits, two light chain subunits, and two regulatory subunits. This gene encodes the alpha heavy chain subunit of cardiac myosin. The gene is located approximately 4kb downstream of the gene encoding the beta heavy chain subunit of cardiac myosin. Mutations in this gene cause familial hypertrophic cardiomyopathy and atrial septal defect 3. [provided by RefSeq, Feb 2017]
MYH6 Gene-Disease associations (from GenCC):
  • hypertrophic cardiomyopathy 14
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Laboratory for Molecular Medicine
  • Keppen-Lubinsky syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Illumina
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • atrial septal defect 3
    Inheritance: AD Classification: LIMITED Submitted by: G2P
  • dilated cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0017161071).
BP6
Variant 14-23386436-A-G is Benign according to our data. Variant chr14-23386436-A-G is described in ClinVar as Benign. ClinVar VariationId is 44522.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.116 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYH6NM_002471.4 linkc.4838T>C p.Val1613Ala missense_variant Exon 33 of 39 ENST00000405093.9 NP_002462.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYH6ENST00000405093.9 linkc.4838T>C p.Val1613Ala missense_variant Exon 33 of 39 5 NM_002471.4 ENSP00000386041.3 P13533

Frequencies

GnomAD3 genomes
AF:
0.0371
AC:
5638
AN:
151894
Hom.:
315
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.119
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0144
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.0170
Gnomad SAS
AF:
0.00728
Gnomad FIN
AF:
0.0000945
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.00491
Gnomad OTH
AF:
0.0255
GnomAD2 exomes
AF:
0.0111
AC:
2775
AN:
250324
AF XY:
0.00941
show subpopulations
Gnomad AFR exome
AF:
0.105
Gnomad AMR exome
AF:
0.00814
Gnomad ASJ exome
AF:
0.00149
Gnomad EAS exome
AF:
0.0138
Gnomad FIN exome
AF:
0.000185
Gnomad NFE exome
AF:
0.00320
Gnomad OTH exome
AF:
0.00930
GnomAD4 exome
AF:
0.00759
AC:
11085
AN:
1460600
Hom.:
285
Cov.:
72
AF XY:
0.00701
AC XY:
5095
AN XY:
726582
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.114
AC:
3764
AN:
33076
American (AMR)
AF:
0.00968
AC:
432
AN:
44648
Ashkenazi Jewish (ASJ)
AF:
0.00130
AC:
34
AN:
26132
East Asian (EAS)
AF:
0.0123
AC:
486
AN:
39654
South Asian (SAS)
AF:
0.00609
AC:
525
AN:
86206
European-Finnish (FIN)
AF:
0.000300
AC:
16
AN:
53420
Middle Eastern (MID)
AF:
0.00678
AC:
39
AN:
5750
European-Non Finnish (NFE)
AF:
0.00454
AC:
5048
AN:
1111394
Other (OTH)
AF:
0.0123
AC:
741
AN:
60320
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.357
Heterozygous variant carriers
0
494
988
1481
1975
2469
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
280
560
840
1120
1400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0372
AC:
5655
AN:
152012
Hom.:
315
Cov.:
32
AF XY:
0.0356
AC XY:
2648
AN XY:
74302
show subpopulations
African (AFR)
AF:
0.119
AC:
4913
AN:
41420
American (AMR)
AF:
0.0144
AC:
220
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
6
AN:
3470
East Asian (EAS)
AF:
0.0171
AC:
88
AN:
5154
South Asian (SAS)
AF:
0.00728
AC:
35
AN:
4806
European-Finnish (FIN)
AF:
0.0000945
AC:
1
AN:
10582
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.00491
AC:
334
AN:
67996
Other (OTH)
AF:
0.0252
AC:
53
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
238
476
715
953
1191
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
56
112
168
224
280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0113
Hom.:
19
Bravo
AF:
0.0429
TwinsUK
AF:
0.00485
AC:
18
ALSPAC
AF:
0.00545
AC:
21
ESP6500AA
AF:
0.0420
AC:
185
ESP6500EA
AF:
0.00186
AC:
16
ExAC
AF:
0.0149
AC:
1806

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:8
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 15, 2016
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 24, 2013
Biesecker Lab/Clinical Genomics Section, National Institutes of Health
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Oct 24, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Dec 27, 2011
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hypertrophic cardiomyopathy 14 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Cardiovascular phenotype Benign:1
Jul 08, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.055
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.41
CADD
Benign
19
DANN
Benign
0.87
DEOGEN2
Benign
0.33
T;T
Eigen
Benign
-0.81
Eigen_PC
Benign
-0.47
FATHMM_MKL
Benign
0.077
N
LIST_S2
Benign
0.47
T;.
MetaRNN
Benign
0.0017
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-2.3
N;N
PhyloP100
8.0
PrimateAI
Uncertain
0.77
T
PROVEAN
Benign
2.6
N;N
REVEL
Benign
0.24
Sift
Benign
1.0
T;T
Sift4G
Benign
1.0
T;T
Polyphen
0.0
B;B
Vest4
0.20
MPC
0.30
ClinPred
0.0080
T
GERP RS
4.5
Varity_R
0.054
gMVP
0.47
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61742476; hg19: chr14-23855645; COSMIC: COSV62450812; COSMIC: COSV62450812; API